Skip to main content

and
  1. No Access

    Article

    Neuroendokrine Neoplasien der Mamma

    Neuroendokrine Neoplasien (NEN) der Mamma sind spezifische Tumorentitäten. Ihre Häufigkeit wird in der Literatur mit bis zu 5 % der malignen epithelialen Neoplasien der Mamma angegeben. Definiert sind NEN der ...

    Prof. Dr. M. Anlauf, M. Neumann, S. Bomberg, K. Luczak, S. Heikaus in Der Pathologe (2015)

  2. No Access

    Article

    The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm

    Gastroenteropancreatic neuroendocrine tumors (NETs) often present as liver metastasis from a carcinoma of unknown primary. We recently showed that primary NETs from the pancreas, small intestine and stomach as...

    D. Kaemmerer, N. Posorski, F. von Eggeling, G. Ernst in Clinical & Experimental Metastasis (2014)

  3. No Access

    Article

    Bedeutung der PET/CT für die Chirurgie neuroendokriner Neoplasien

    Neuroendokrine Neoplasien (NEN) sind seltene Malignome mit unterschiedlichem Metastasierungsverhalten, die den endokrinen Zellen des Körpers entstammen und Somatostatinrezeptoren aufweisen. Die 68Ga-Somatostatinr...

    PD Dr. M. Hommann, D. Kaemmerer, D. Hörsch, H.R. Kulkarni, F. Robiller in Der Chirurg (2014)

  4. No Access

    Article

    Neuroendokrine Neoplasien des distalen Jejunums und Ileums

    Neuroendokrine Neoplasien (NEN) des distalen Jejunums und Ileums leiten sich von den serotoninproduzierenden enterochromaffinen Zellen (EC-Zellen) ab. Aufgrund ihrer niedrigen proliferativen Aktivität und ihre...

    Prof. Dr. M. Anlauf, B. Sipos, I. Boeck, S.E. Baldus, S. Heikaus in Der Pathologe (2014)

  5. Article

    Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

    L. Bodei, J. Mueller-Brand, R. P. Baum in European Journal of Nuclear Medicine and M… (2014)

  6. Article

    Open Access

    The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

    Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy involving the systemic administration of a radiolabelled peptide designed to target with high affinity and specificity ...

    John J. Zaknun, L. Bodei, J. Mueller-Brand in European Journal of Nuclear Medicine and M… (2013)

  7. Article

    Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death

    Pro-inflammatory cytokines play a crucial role in immune-mediated beta cell destruction, an essential mechanism in the pathogenesis of type 1 diabetes mellitus. Microarray analysis recently identified osteopro...

    J. Schrader, W. Rennekamp, U. Niebergall, M. Schoppet, H. Jahr in Diabetologia (2007)

  8. Article

    The Rap–B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells

    Glucose and glucagon-like peptide-1 have been shown to activate extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase in beta cells. We examined the contributions of the small GTPases Rap a...

    J. Trümper, D. Ross, H. Jahr, M. D. Brendel, R. Göke, D. Hörsch in Diabetologia (2005)

  9. No Access

    Article

    Elevated density and plasticity of nerve fibres in anal fissures

    Neural proliferative processes are regarded as a contributing factor in chronic inflammatory diseases and chronic pain. To elucidate whether neural proliferations occur in tissues surrounding chronic anal fis...

    D. Hörsch, J. J. Kirsch, E. Weihe in International Journal of Colorectal Disease (1998)